Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sucralfate Suspensoid Gel consolidation after standard quadruple therapy for Helicobacter pylori-associated gastritis
ChiCTR2000041211Phase 4Recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sucralfate in Helicobacter pylori-associated gastritis (2 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoints: Assessment of mucosal damage and Helicobacter pylori eradication rate after treatment. Started Dec 2020; status: recruiting.
02
Drugs
sucralfate
03
Conditions
Helicobacter pylori-associated gastritis
Beyond the preview
Go deeper on ChiCTR2000041211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041211.